Update: Ongoing Zika Virus Transmission — Puerto Rico, November 1, 2015–April 14, 2016
- 6 May 2016
- journal article
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 65 (17) , 451-455
Abstract
Zika virus is a flavivirus transmitted primarily by Aedes species mosquitoes, and symptoms of infection can include rash, fever, arthralgia, and conjunctivitis (1).* Zika virus infection during pregnancy is a cause of microcephaly and other severe brain defects (2). Infection has also been associated with Guillain-Barré syndrome (3). In December 2015, Puerto Rico became the first U.S. jurisdiction to report local transmission of Zika virus, with the index patient reporting symptom onset on November 23, 2015 (4). This report provides an update to the epidemiology of and public health response to ongoing Zika virus transmission in Puerto Rico. During November 1, 2015-April 14, 2016, a total of 6,157 specimens from suspected Zika virus-infected patients were evaluated by the Puerto Rico Department of Health (PRDH) and CDC Dengue Branch (which is located in San Juan, Puerto Rico), and 683 (11%) had laboratory evidence of current or recent Zika virus infection by one or more tests: reverse transcription-polymerase chain reaction (RT-PCR) or immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA). Zika virus-infected patients resided in 50 (64%) of 78 municipalities in Puerto Rico. Median age was 34 years (range = 35 days-89 years). The most frequently reported signs and symptoms were rash (74%), myalgia (68%), headache (63%), fever (63%), and arthralgia (63%). There were 65 (10%) symptomatic pregnant women who tested positive by RT-PCR or IgM ELISA. A total of 17 (2%) patients required hospitalization, including 5 (1%) patients with suspected Guillain-Barré syndrome. One (<1%) patient died after developing severe thrombocytopenia. The public health response to the outbreak has included increased laboratory capacity to test for Zika virus infection (including blood donor screening), implementation of enhanced surveillance systems, and prevention activities focused on pregnant women. Vector control activities include indoor and outdoor residual spraying and reduction of mosquito breeding environments focused around pregnant women's homes. Residents of and travelers to Puerto Rico should continue to employ mosquito bite avoidance behaviors, take precautions to reduce the risk for sexual transmission (5), and seek medical care for any acute illness with rash or fever.Keywords
This publication has 10 references indexed in Scilit:
- Zika Virus and Birth Defects — Reviewing the Evidence for CausalityNew England Journal of Medicine, 2016
- Zika virus associated deaths in ColombiaThe Lancet Infectious Diseases, 2016
- Zika VirusNew England Journal of Medicine, 2016
- Survey of Blood Collection Centers and Implementation of Guidance for Prevention of Transfusion-Transmitted Zika Virus Infection — Puerto Rico, 2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical Characterization, Epidemiological and Virological AspectsPLOS Neglected Tropical Diseases, 2016
- Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak — Puerto Rico, 2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus — United States, 2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure — United States, 2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyThe Lancet, 2016
- Local Transmission of Zika Virus — Puerto Rico, November 23, 2015–January 28, 2016MMWR. Morbidity and Mortality Weekly Report, 2016